Search

Search Results
Results 17981 - 17990 of 18039 for breast cancer
  • Trumenba
    Drug - 16 Nov 2022
    Consumer Medicine Information (CMI) about Trumenba intended for persons living in Australia.
  • Entecavir Viatris
    Drug - 6 Nov 2022
    Consumer Medicine Information (CMI) about Entecavir Viatris (Entecavir) intended for persons living in Australia.
  • Tobramycin Injection
    Drug - 7 Oct 2022
    Consumer Medicine Information (CMI) about Tobramycin Injection (tobramycin sulfate) intended for persons living in Australia.
  • DBL Tobramycin Injection
    Drug - 7 Oct 2022
    Consumer Medicine Information (CMI) about DBL Tobramycin Injection (tobramycin) intended for persons living in Australia.
  • Tobramycin PF
    Drug - 7 Oct 2022
    Consumer Medicine Information (CMI) about Tobramycin PF (tobramycin) intended for persons living in Australia.
  • Endometrin
    Drug - 28 Sep 2022
    Consumer Medicine Information (CMI) about Endometrin intended for persons living in Australia.
  • Heparinised Saline Injection
    Drug - 27 Sep 2022
    Consumer Medicine Information (CMI) about Heparinised Saline Injection intended for persons living in Australia.
  • Tenofovir Disoproxil Viatris
    Drug - 23 Sep 2022
    Consumer Medicine Information (CMI) about Tenofovir Disoproxil Viatris (tenofovir disoproxil maleate 300 mg) intended for persons living in Australia.
  • Jardiamet
    Drug - 21 Sep 2022
    Consumer Medicine Information (CMI) about Jardiamet (empagliflozin / metformin hydrochloride) intended for persons living in Australia.
  • Accupril
    Drug - 2 Sep 2022
    Consumer Medicine Information (CMI) about Accupril intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback